Research Antibodies Market (By Product: Primary, Secondary; By Type: Monoclonal Antibodies, Polyclonal Antibodies; By Technology: Immunohistochemistry, Immunofluorescence, Western Blotting, Flow Cytometry, Immunoprecipitation, ELISA, Other Technologies; By Source: Mouse, Rabbit, Goat, Other Sources; By Application :Infectious Diseases, Immunology, Oncology, Stem Cells, Neurobiology, Other Applications; By End-use: Academic & Research Institutes, Contract Research Organizations, Pharmaceutical & Biotechnology Companies) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 20212030

Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Research Antibodies Market, By Product Type

7.1.  Research Antibodies Market, By Product Type, 2020-2030

7.1.1.    Primary

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Secondary

7.1.2.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Research Antibodies Market, By Type

8.1.  Research Antibodies Market, By Type, 2020-2030

8.1.1.    Monoclonal

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Polyclonal

8.1.2.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Research Antibodies Market, By Technology Type

9.1.  Research Antibodies Market, by Technology Type, 2020-2030

9.1.1.    Immunohistochemistry

9.1.1.1.        Market Revenue and Forecast (2016-2030)

9.1.2.    Immunofluorescence

9.1.2.1.        Market Revenue and Forecast (2016-2030)

9.1.3.    Western Blotting

9.1.3.1.        Market Revenue and Forecast (2016-2030)

9.1.4.    Flow Cytometry

9.1.4.1.        Market Revenue and Forecast (2016-2030)

9.1.5.    Immunoprecipitation

9.1.5.1.        Market Revenue and Forecast (2016-2030)

9.1.6.    ELISA

9.1.6.1.        Market Revenue and Forecast (2016-2030)

9.1.7.    Other Technologies

9.1.7.1.        Market Revenue and Forecast (2016-2030)

Chapter 10.      Global Research Antibodies Market, By Source Type

10.1.        Research Antibodies Market, By Source Type, 2020-2030

10.1.1.  Mouse

10.1.1.1.      Market Revenue and Forecast (2016-2030)

10.1.2.  Rabbit

10.1.2.1.      Market Revenue and Forecast (2016-2030)

10.1.3.  Goat

10.1.3.1.      Market Revenue and Forecast (2016-2030)

10.1.4.  Other Sources

10.1.4.1.      Market Revenue and Forecast (2016-2030)

Chapter 11.      Global Research Antibodies Market, By Application

11.1.        Research Antibodies Market, By Application, 2020-2030

11.1.1.  Infectious Diseases

11.1.1.1.      Market Revenue and Forecast (2016-2030)

11.1.2.  Immunology

11.1.2.1.      Market Revenue and Forecast (2016-2030)

11.1.3.  Oncology

11.1.3.1.      Market Revenue and Forecast (2016-2030)

11.1.4.  Stem Cells

11.1.4.1.      Market Revenue and Forecast (2016-2030)

11.1.5.  Neurobiology

11.1.5.1.      Market Revenue and Forecast (2016-2030)

11.1.6.  Other Applications

11.1.6.1.      Market Revenue and Forecast (2016-2030)

Chapter 12.      Global Research Antibodies Market, By End-use

12.1.        Research Antibodies Market, By Type, 2020-2030

12.1.1.  Academic & Research Institutes

12.1.1.1.      Market Revenue and Forecast (2016-2030)

12.1.2.  CROs

12.1.2.1.      Market Revenue and Forecast (2016-2030)

12.1.3.  Pharmaceutical & Biotechnology Companies

12.1.3.1.      Market Revenue and Forecast (2016-2030)

Chapter 13.      Global Research Antibodies  Market, Regional Estimates and Trend Forecast

13.1.        North America

13.1.1.  Market Revenue and Forecast, By Product (2016-2030)

13.1.2.  Market Revenue and Forecast, By Type (2016-2030)

13.1.3.  Market Revenue and Forecast, by Technology (2016-2030)

13.1.4.  Market Revenue and Forecast, By Source (2016-2030)

13.1.5.  Market Revenue and Forecast, By Application (2016-2030)

13.1.6.  Market Revenue and Forecast, By End-use (2016-2030)

13.1.7.  U.S.

13.1.7.1.      Market Revenue and Forecast, By Product (2016-2030)

13.1.7.2.      Market Revenue and Forecast, By Type (2016-2030)

13.1.7.3.      Market Revenue and Forecast, by Technology (2016-2030)

13.1.7.4.      Market Revenue and Forecast, By Source (2016-2030)

13.1.8.  Market Revenue and Forecast, By Application (2016-2030)

13.1.8.1.      Market Revenue and Forecast, By End-use (2016-2030)

13.1.9.  Rest of North America

13.1.9.1.      Market Revenue and Forecast, By Product (2016-2030)

13.1.9.2.      Market Revenue and Forecast, By Type (2016-2030)

13.1.9.3.      Market Revenue and Forecast, by Technology (2016-2030)

13.1.9.4.      Market Revenue and Forecast, By Source (2016-2030)

13.1.10.               Market Revenue and Forecast, By Application (2016-2030)

13.1.11.               Market Revenue and Forecast, By End-use (2016-2030)

13.1.11.1.    

13.2.        Europe

13.2.1.  Market Revenue and Forecast, By Product (2016-2030)

13.2.2.  Market Revenue and Forecast, By Type (2016-2030)

13.2.3.  Market Revenue and Forecast, by Technology (2016-2030)

13.2.4.  Market Revenue and Forecast, By Source (2016-2030)

13.2.5.  Market Revenue and Forecast, By Application (2016-2030)

13.2.6.  Market Revenue and Forecast, By End-use (2016-2030)

13.2.7.   

13.2.8.  UK

13.2.8.1.      Market Revenue and Forecast, By Product (2016-2030)

13.2.8.2.      Market Revenue and Forecast, By Type (2016-2030)

13.2.8.3.      Market Revenue and Forecast, by Technology (2016-2030)

13.2.9.  Market Revenue and Forecast, By Source (2016-2030)

13.2.10.               Market Revenue and Forecast, By Application (2016-2030)

13.2.10.1.   Market Revenue and Forecast, By End-use (2016-2030)

13.2.11.               Germany

13.2.11.1.   Market Revenue and Forecast, By Product (2016-2030)

13.2.11.2.   Market Revenue and Forecast, By Type (2016-2030)

13.2.11.3.   Market Revenue and Forecast, by Technology (2016-2030)

13.2.12.               Market Revenue and Forecast, By Source (2016-2030)

13.2.13.               Market Revenue and Forecast, By Application (2016-2030)

13.2.14.               Market Revenue and Forecast, By End-use (2016-2030)

13.2.14.1.    

13.2.15.               France

13.2.15.1.   Market Revenue and Forecast, By Product (2016-2030)

13.2.15.2.   Market Revenue and Forecast, By Type (2016-2030)

13.2.15.3.   Market Revenue and Forecast, by Technology (2016-2030)

13.2.15.4.   Market Revenue and Forecast, By Source (2016-2030)

13.2.16.               Market Revenue and Forecast, By Application (2016-2030)

13.2.16.1.   Market Revenue and Forecast, By End-use (2016-2030)

13.2.17.               Rest of Europe

13.2.17.1.   Market Revenue and Forecast, By Product (2016-2030)

13.2.17.2.   Market Revenue and Forecast, By Type (2016-2030)

13.2.17.3.   Market Revenue and Forecast, by Technology (2016-2030)

13.2.17.4.   Market Revenue and Forecast, By Source (2016-2030)

13.2.18.               Market Revenue and Forecast, By Application (2016-2030)

13.2.18.1.   Market Revenue and Forecast, By End-use (2016-2030)

13.3.        APAC

13.3.1.  Market Revenue and Forecast, By Product (2016-2030)

13.3.2.  Market Revenue and Forecast, By Type (2016-2030)

13.3.3.  Market Revenue and Forecast, by Technology (2016-2030)

13.3.4.  Market Revenue and Forecast, By Source (2016-2030)

13.3.5.  Market Revenue and Forecast, By Application (2016-2030)

13.3.6.  Market Revenue and Forecast, By End-use (2016-2030)

13.3.7.  India

13.3.7.1.      Market Revenue and Forecast, By Product (2016-2030)

13.3.7.2.      Market Revenue and Forecast, By Type (2016-2030)

13.3.7.3.      Market Revenue and Forecast, by Technology (2016-2030)

13.3.7.4.      Market Revenue and Forecast, By Source (2016-2030)

13.3.8.  Market Revenue and Forecast, By Application (2016-2030)

13.3.9.  Market Revenue and Forecast, By End-use (2016-2030)

13.3.10.               China

13.3.10.1.   Market Revenue and Forecast, By Product (2016-2030)

13.3.10.2.   Market Revenue and Forecast, By Type (2016-2030)

13.3.10.3.   Market Revenue and Forecast, by Technology (2016-2030)

13.3.10.4.   Market Revenue and Forecast, By Source (2016-2030)

13.3.11.               Market Revenue and Forecast, By Application (2016-2030)

13.3.11.1.   Market Revenue and Forecast, By End-use (2016-2030)

13.3.12.               Japan

13.3.12.1.   Market Revenue and Forecast, By Product (2016-2030)

13.3.12.2.   Market Revenue and Forecast, By Type (2016-2030)

13.3.12.3.   Market Revenue and Forecast, by Technology (2016-2030)

13.3.12.4.   Market Revenue and Forecast, By Source (2016-2030)

13.3.12.5.   Market Revenue and Forecast, By Application (2016-2030)

13.3.12.6.   Market Revenue and Forecast, By End-use (2016-2030)

13.3.13.               Rest of APAC

13.3.13.1.   Market Revenue and Forecast, By Product (2016-2030)

13.3.13.2.   Market Revenue and Forecast, By Type (2016-2030)

13.3.13.3.   Market Revenue and Forecast, by Technology (2016-2030)

13.3.13.4.   Market Revenue and Forecast, By Source (2016-2030)

13.3.13.5.   Market Revenue and Forecast, By Application (2016-2030)

13.3.13.6.   Market Revenue and Forecast, By End-use (2016-2030)

13.4.        MEA

13.4.1.  Market Revenue and Forecast, By Product (2016-2030)

13.4.2.  Market Revenue and Forecast, By Type (2016-2030)

13.4.3.  Market Revenue and Forecast, by Technology (2016-2030)

13.4.4.  Market Revenue and Forecast, By Source (2016-2030)

13.4.5.  Market Revenue and Forecast, By Application (2016-2030)

13.4.6.  Market Revenue and Forecast, By End-use (2016-2030)

13.4.7.  GCC

13.4.7.1.      Market Revenue and Forecast, By Product (2016-2030)

13.4.7.2.      Market Revenue and Forecast, By Type (2016-2030)

13.4.7.3.      Market Revenue and Forecast, by Technology (2016-2030)

13.4.7.4.      Market Revenue and Forecast, By Source (2016-2030)

13.4.8.  Market Revenue and Forecast, By Application (2016-2030)

13.4.9.  Market Revenue and Forecast, By End-use (2016-2030)

13.4.10.               North Africa

13.4.10.1.   Market Revenue and Forecast, By Product (2016-2030)

13.4.10.2.   Market Revenue and Forecast, By Type (2016-2030)

13.4.10.3.   Market Revenue and Forecast, by Technology (2016-2030)

13.4.10.4.   Market Revenue and Forecast, By Source (2016-2030)

13.4.11.               Market Revenue and Forecast, By Application (2016-2030)

13.4.12.               Market Revenue and Forecast, By End-use (2016-2030)

13.4.13.               South Africa

13.4.13.1.   Market Revenue and Forecast, By Product (2016-2030)

13.4.13.2.   Market Revenue and Forecast, By Type (2016-2030)

13.4.13.3.   Market Revenue and Forecast, by Technology (2016-2030)

13.4.13.4.   Market Revenue and Forecast, By Source (2016-2030)

13.4.13.5.   Market Revenue and Forecast, By Application (2016-2030)

13.4.13.6.   Market Revenue and Forecast, By End-use (2016-2030)

13.4.14.               Rest of MEA

13.4.14.1.   Market Revenue and Forecast, By Product (2016-2030)

13.4.14.2.   Market Revenue and Forecast, By Type (2016-2030)

13.4.14.3.   Market Revenue and Forecast, by Technology (2016-2030)

13.4.14.4.   Market Revenue and Forecast, By Source (2016-2030)

13.4.14.5.   Market Revenue and Forecast, By Application (2016-2030)

13.4.14.6.   Market Revenue and Forecast, By End-use (2016-2030)

13.5.        Latin America

13.5.1.  Market Revenue and Forecast, By Product (2016-2030)

13.5.2.  Market Revenue and Forecast, By Type (2016-2030)

13.5.3.  Market Revenue and Forecast, by Technology (2016-2030)

13.5.4.  Market Revenue and Forecast, By Source (2016-2030)

13.5.5.  Market Revenue and Forecast, By Application (2016-2030)

13.5.6.  Market Revenue and Forecast, By End-use (2016-2030)

13.5.7.  Brazil

13.5.7.1.      Market Revenue and Forecast, By Product (2016-2030)

13.5.7.2.      Market Revenue and Forecast, By Type (2016-2030)

13.5.7.3.      Market Revenue and Forecast, by Technology (2016-2030)

13.5.7.4.      Market Revenue and Forecast, By Source (2016-2030)

13.5.8.  Market Revenue and Forecast, By Application (2016-2030)

13.5.8.1.      Market Revenue and Forecast, By End-use (2016-2030)

13.5.9.  Rest of LATAM

13.5.9.1.      Market Revenue and Forecast, By Product (2016-2030)

13.5.9.2.      Market Revenue and Forecast, By Type (2016-2030)

13.5.9.3.      Market Revenue and Forecast, by Technology (2016-2030)

13.5.9.4.      Market Revenue and Forecast, By Source (2016-2030)

13.5.9.5.      Market Revenue and Forecast, By Application (2016-2030)

13.5.9.6.      Market Revenue and Forecast, By End-use (2016-2030)

Chapter 14.  Company Profiles

14.1.              Abcam Plc

14.1.1.  Company Overview

14.1.2.  Product Offerings

14.1.3.  Financial Performance

14.1.4.  Recent Initiatives

14.2.              Bio-Rad Laboratories Inc.

14.2.1.  Company Overview

14.2.2.  Product Offerings

14.2.3.  Financial Performance

14.2.4.  Recent Initiatives

14.3.              PerkinElmer, Inc.

14.3.1.  Company Overview

14.3.2.  Product Offerings

14.3.3.  Financial Performance

14.3.4.  Recent Initiatives

14.4.              Agilent Technologies

14.4.1.  Company Overview

14.4.2.  Product Offerings

14.4.3.  Financial Performance

14.4.4.  Recent Initiatives

14.5.              Roche

14.5.1.  Company Overview

14.5.2.  Product Offerings

14.5.3.  Financial Performance

14.5.4.  Recent Initiatives

14.6.              Cell Signalling Technology, Inc.

14.6.1.  Company Overview

14.6.2.  Product Offerings

14.6.3.  Financial Performance

14.6.4.  Recent Initiatives

14.7.              Thermo Fisher Scientific

14.7.1.  Company Overview

14.7.2.  Product Offerings

14.7.3.  Financial Performance

14.7.4.  Recent Initiatives

14.8.              Lonza Group

14.8.1.  Company Overview

14.8.2.  Product Offerings

14.8.3.  Financial Performance

14.8.4.  Recent Initiatives

14.9.              BD

14.9.1.  Company Overview

14.9.2.  Product Offerings

14.9.3.  Financial Performance

14.9.4.  Recent Initiatives

Chapter 15.  Research Methodology

15.1.              Primary Research

15.2.              Secondary Research

15.3.              Assumptions

Chapter 16.  Appendix

16.1.              About Us

Glossary of Terms

Report Details

  • Report Code:35364
  • Category:Healthcare
  • No. of Pages:250
  • Format:PDF/PPT/Excel
  • Published:August 2022
  • Historical Year:2021-2022
  • Base Year:2023
  • Estimated Year:2024-2033

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers